Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of everolimus in patients with treatment-refractory vascular anomalies. The study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Malformations
• Hemangioendothelioma
• Hemangioma
• Lymphangioma
• Port-wine Stain
• Vascular Malformations
• Venous Malformation

Drugs mentioned

• Afinitor (everolimus)
• Everolimus (everolimus)

Snippet

Sponsor: Yonsei University | Conditions: Vascular Malformations, Arteriovenous Malformations | Phase 2 | Status: NOT_YET_RECRUITING